In Vivo Depletion of CD25+ Cells Prior to LRAST Increases Therapeutic Efficacy in a Murine Melanoma Model

Journal for ImmunoTherapy of Cancer - United Kingdom
doi 10.1186/2051-1426-2-s3-p51

Related search